Infections Deaths in the PLATO Trial

Background Cardiovascular benefits of aggressive dual antiplatelet therapy may be associated with extra risks including bleeding, cancer, and infections discovered first for prasugrel in the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel (TRITON)...

Full description

Saved in:
Bibliographic Details
Main Authors: Victor Serebruany, Jean-Francois Tanguay
Format: article
Language:EN
Published: Georg Thieme Verlag KG 2021
Subjects:
Online Access:https://doaj.org/article/21f0efbfbda84e639dc973214dd37e3d
Tags: Add Tag
No Tags, Be the first to tag this record!